IQVIA Holdings Inc.’s stock price soars to $153.30, marking an impressive +4.86% increase

IQVIA Holdings Inc. (IQV)

153.30 USD +7.10 (+4.86%) Volume: 2.88M

IQVIA Holdings Inc.’s stock price soared to 153.30 USD, marking a significant session uptick of +4.86% with a trading volume of 2.88M, despite a YTD decrease of -21.99%, highlighting the company’s dynamic market performance.

Latest developments on IQVIA Holdings Inc.

IQVIA Holdings Inc. stock has been outperforming competitors, with strong financial performance and a promising outlook despite market challenges. Recently, Baird adjusted the price target on IQVIA Holdings to $161, while Barclays lowered their price target to $165. The company reported $3,829 million in sales for Q1 2025 and raised their full-year revenue guidance. IQVIA CFO Ron Bruehlman is set to speak at the Bank of America Annual Health Care Conference on May 13. Despite beating Q1 2025 EPS forecasts, the stock dipped after the earnings call. However, IQVIA Holdings remains resilient and continues to show growth prospects, driving a buy rating amid industry challenges. Overall, IQVIA Holdings has been navigating market conditions effectively, exceeding profit estimates and raising revenue forecasts.

A look at IQVIA Holdings Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

IQVIA Holdings Inc. has a promising long-term outlook, according to Smartkarma Smart Scores. With a strong score of 4 for Growth, the company is expected to see significant expansion and development in the future. This is further supported by scores of 3 for both Resilience and Momentum, indicating a stable and consistent performance with positive market momentum.

Although IQVIA Holdings scores lower in Dividend at 1, the company’s overall outlook remains positive with a Value score of 3. As a company focusing on technology solutions and contract research services for various industries globally, including consumer health and biopharma, IQVIA Holdings is well-positioned for continued growth and success in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma